Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-22

Clinical Trial Update: Long Term Follow-Up for Safety of AVR-RD-02

View source ↗

Summary

This is a long-term follow-up safety study of AVR-RD-02 for Gaucher disease, currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVR-RD-02

Snippet

Sponsor: John Bernat | Conditions: Gaucher Disease | Status: ACTIVE_NOT_RECRUITING